University of Toronto - Department of Nutritional Sciences
Toronto, Ontario, M5S 3E2, Canada
NCT Number: NCT01242059
It is hypothesized that yellow pea protein and fiber will reduce short-term food intake, subjective appetite and glycemic response.
Looking for future studies?
Notify Me20 year–29 year
Male
Interventional
Not applicable
Toronto, Ontario, M5S 3E2, Canada
A within-subject, randomized study was conducted. Each subject returned 5 times, 1 week apart, and received 1 of the 5 treatments per week. The 5 treatments were tomato soup with 10 or 20 g of isolated yellow pea fibre or protein, or a control soup with no added pea fractions. Food intake was measured at an ad libitum pizza meal served 2 hours after treatment. Satiety and blood glucose (via finger prick) were measured throughout the treatment period.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Served in a tomato soup
Served in a tomato soup
Served in a tomato soup
Time frame: at 120 minutes after treatment
Energy intake at an ad libitum pizza meal
Time frame: 200 minutes
Time frame: 200 minutes
University of Toronto
Other
Effect of Yellow Pea Fractions on Short-term Food Intake at 120 Minutes, Subjective Appetite and Glycemic Response in Young Adult Males
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01255085
Body Weight, Diabetes Mellitus
Toronto, Ontario, Canada
View Trial DetailsNCT06461273
Behavior, Body Weight
Newark, New Jersey, United States
View Trial DetailsNCT06186102
Arterial Occlusive Diseases, Arteriosclerosis
Aarhus, Jutland, Denmark
View Trial DetailsNCT01283113
Body Weight, Diabetes Mellitus
Boston, Massachusetts, United States
View Trial Details